Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials Robert C. Doebele , Alexander Drilon , Luis Paz‐Ares +35 more Ignyta/F Hoffmann-La Roche. 2019 The Lancet Oncology 1625 citations